Safety and Efficacy of ADVM-022 in Treatment-Experienced Patients With Neovascular Age-related Macular Degeneration [LUNA]
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05536973 |
|
Recruitment Status :
Active, not recruiting
First Posted : September 13, 2022
Last Update Posted : January 8, 2024
|
Sponsor:
Adverum Biotechnologies, Inc.
Collaborator:
Parexel
Information provided by (Responsible Party):
Adverum Biotechnologies, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Estimated Primary Completion Date : | August 2028 |
| Estimated Study Completion Date : | November 2028 |